90 results
In this post hoc analysis trial, screening for bradyarrhythmia with an implantable loop recorder led to overtreatment without reducing sudden cardiac death.
The Quadruple Aim is a framework designed to help hospitals improve patient outcomes and the quality of care provided. Dive deeper into this framework and its components with EBSCO Health CNO, Diane Hanson.
A locally acquired case of vaccine-derived polio in New York has prompted public health surveillance and polio vaccine drives. Here’s what you need to know.
There is still so much to understand about E-cigarette or Vaping product use Associated Lung Injury (EVALI). Here’s what we know.
Explore GIDEON’s user-centric approach to transforming its interface to meet the diverse needs of modern clinical and academic users. Read a first-hand account from GIDEON Director, Product Development and Marketing, Kristina Symes.
EBSCO’s Health Implementation Manager, Amy Purello, RN, BSN reflects on lessons learned while serving as a Navy nurse and how those lessons can be applied to nursing in 2020.
COVID-19 is associated with coagulopathy and risk for thrombotic complications, but not all patients should get anticoagulation. Here is a new tool from the DynaMed Decisions® team at EBSCO that takes the guess work out of this clinical decision.
It’s not magic, but the magnitude of benefit for psilocybin compared to other available treatments for major depressive disorder plus its relative lack of adverse effects suggests that this treatment might be about ready for prime time.
What global health issues should we keep an eye on in 2021? Dr. Stephen A. Berger co-founder of GIDEON (Global Infectious Diseases and Epidemiology Network) outlines five candidates that may re-emerge post-pandemic.
While the COVID-19 pandemic continues to impact people worldwide, it is not the only coronavirus the world is battling in 2020. The MERS outbreak is still ongoing in the Middle East. Learn more about MERS from our partners at GIDEON.